Catecholamines like dopamine bind to enkephalins and morphiceptin, suggesting a molecular basis for their co-transmission. This interaction may explain opiate effects and inform drug design.
Area of Science:
Neuroscience
Biochemistry
Pharmacology
Background:
Catecholamines (dopamine, epinephrine, norepinephrine) and enkephalins are neurotransmitters involved in various physiological processes.
The co-storage and co-transmission of these molecules have been observed but the underlying mechanisms remain unclear.
Purpose of the Study:
To investigate the molecular interactions between catecholamines and enkephalins.
To explore potential binding sites and affinities between these neurotransmitter classes.
Main Methods:
Nuclear magnetic resonance (NMR) spectroscopy
pH titration
Colorimetric assays
Main Results:
Demonstrated direct binding of catecholamines (dopamine, epinephrine, norepinephrine) to enkephalins and morphiceptin with binding constants around 6 x 10^3 M^-1.
Showed that intact enkephalin and morphiceptin molecules are required for binding, not fragments.
Found that serotonin binding peptides do not bind catecholamines, but morphine and apomorphine do bind catecholamines (morphine K_d ~ 4 x 10^4 M^-1).
Observed that morphine, morphiceptin, and enkephalins inhibit catecholamine color reactions in vitro.
Conclusions:
These findings provide a molecular basis for the co-transmission of catecholamines and enkephalins.
The results may elucidate other peptide-monoamine co-transmission systems.
The study offers insights into opiate effects on catecholamines and suggests avenues for drug design.